Cargando…
Metformin and bladder cancer: Drug repurposing as a potential tool for novel therapy: A review
Bladder cancer (BC) is a common type of cancer worldwide. Currently, the gold standard treatment is transurethral resection of bladder tumor (TUR-Bt) accompanied by intravesical Bacillus Calmette–Guérin (BCG) instillation for patients with middle-to-high-risk non-muscle-invasive bladder cancer (NMIB...
Autores principales: | Feng, Yunzhu, Jia, Benzhong, Shen, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666131/ https://www.ncbi.nlm.nih.gov/pubmed/36397350 http://dx.doi.org/10.1097/MD.0000000000031635 |
Ejemplares similares
-
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases
por: Zhang, Ye, et al.
Publicado: (2019) -
CCNB2 as a potential biomarker of bladder cancer via the high throughput technology
por: Zhang, Lei, et al.
Publicado: (2023) -
The histocompatibility research of hair follicle stem cells with bladder acellular matrix
por: Li, Jia, et al.
Publicado: (2016) -
High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma
por: Liu, Bin, et al.
Publicado: (2023) -
Primary bladder mucosa-associated lymphoid tissue lymphoma: A case report and literature review
por: Xu, Hewei, et al.
Publicado: (2020)